Effects of a mind-body program on symptoms of depression and perceived stress among adults with neurofibromatosis type 2 who are deaf: A live-video randomized controlled trial. (January 2021)

• Record Type: Journal Article
• Authors: Carter, Sarah; Greenberg, Jonathan; Funes, Christopher J.; Macklin, Eric A.; Vranceanu, Ana-Maria
• Is Part Of: Complementary therapies in medicine. Volume 56(2021)
• Publication Date: 2021-01
• Subjects: Neurofibromatosis type 2 -- Mind–body intervention -- Depression -- Perceived stress; Alternative medicine -- Periodicals; Complementary Therapies -- Periodicals; Médecines parallèles -- Périodiques; Thérapeutique -- Périodiques; Alternative medicine; Electronic journals; Periodicals; 615.5
• DOI: 10.1016/j.ctim.2020.102581
• Languages: English
• ISSNs: 0965-2299

Abstract

Highlights: Targeted mind-body intervention was successful in reducing depression and stress in NF2. Sessions were delivered on video with real-time translation for patients who are deaf. Improvements in depression and stress following intervention are long-lasting. Abstract: Introduction: Neurofibromatosis type 2 (NF2) is a rare, progressive and incurable genetic disorder associated with progressive hearing loss and eventual deafness. As a group, patients with NF report high levels of stress and depressive symptoms. However, no studies have explored improvement in these symptoms after psychosocial interventions. We have previously shown that a mind-body program tailored to adults with NF2 who are deaf (the Relaxation Response and Resiliency Program for Deaf NF2, d3RP-NF2) improves quality of life and resiliency over and above a Health Enhancement program when both are delivered via live-video and assisted by Communication Access Realtime Translation (CART). Here we tested the effects of the programs on depression and perceived stress. Methods: Forty-five patients with NF2 and significant hearing loss were randomized to the d3RP-NF2 or Health-Enhancement program and completed measures of depression (PHQ-9) and perceived stress (PSS-10) at baseline, post-intervention, and six-month follow-up. Results: Patients randomized to the d3RP-NF2 program, but not to the control condition, experienced significant decreases on both measures from baseline to post-test, which were maintained at follow-up (within group tests). However, improvements following the d3RP-NF2 program was not significantly higher than those observed in the control group (between group tests). Conclusion: Results provide the first evidence of improvement in symptoms of depression and perceived stress among deaf patients living with NF2 who participate in a virtual mind-body program.